2026. COMPREHENSIVE ASSESSMENT OF IMMUNOBIOCHEMICAL MARKERS IN THE DIAGNOSIS OF BRONCHIAL ASTHMA IN COMORBID COURSE WITH TYPE 2 DIABETES MELLITUS. Web of Scientists and Scholars: Journal of Multidisciplinary Research. 4, 3 (Mar. 2026), 47–56.